Johns Hopkins researchers revealed that a three-pronged immunotherapy treatment, which is safe for patients, showed promise in increasing cancer-killing immune cells.
Researchers have revealed a mechanism behind drug-resistant tumors and one possible solution: combination therapy with a popular dietary supplement, N-acetylcysteine.
Potentially groundbreaking research by a team at the University of Iowa is creating new, biocompatible materials that may figuratively spray cancer away.